东方生物,688298,收入构成,报告日期,2019-12-31,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
体外诊断行业,36261,18877,17384,47.94%,99.61%
其他（补充）,476,408,68,14.25%,0.39%


